Carlos Nueno - 30 May 2025 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role
President, International
Signature
/s/ Adam C. Vandervoort, Attorney-in-Fact
Issuer symbol
TDOC
Transactions as of
30 May 2025
Net transactions value
-$27,152
Form type
4
Filing time
03 Jun 2025, 17:36:29 UTC
Previous filing
21 Mar 2025
Next filing
03 Sep 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Nueno Carlos President, International C/O TELADOC HEALTH, INC.,, 155 E 44TH ST, FLOOR 17, NEW YORK /s/ Adam C. Vandervoort, Attorney-in-Fact 03 Jun 2025 0002037711

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TDOC Common Stock Options Exercise +3,100 +24% 15,991 30 May 2025 Direct F1
transaction TDOC Common Stock Options Exercise +1,056 +6.6% 17,047 30 May 2025 Direct F2
transaction TDOC Common Stock Options Exercise +4,556 +27% 21,603 30 May 2025 Direct F1
transaction TDOC Common Stock Sale $27,152 -3,958 -18% $6.86 17,645 02 Jun 2025 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TDOC Restricted Stock Units Options Exercise $0 -3,100 -25% $0.000000 9,302 30 May 2025 Common Stock 3,100 Direct F1, F4
transaction TDOC Performance Stock Units Options Exercise $0 -1,056 -25% $0.000000 3,173 30 May 2025 Common Stock 1,056 Direct F2, F5
transaction TDOC Restricted Stock Units Options Exercise $0 -4,556 -12% $0.000000 31,894 30 May 2025 Common Stock 4,556 Direct F1, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F2 Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
F3 Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
F4 On March 3, 2023, the reporting person was granted 37,202 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F5 On March 1, 2024, the reporting person earned 12,679 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F6 On March 19, 2024, the reporting person was granted 54,675 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025.